SCHEMBL5429656

SCHEMBL5429656

Cn1c(-c2ccc(Cl)cc2)nc2c(=O)[nH]cnc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ADORA3 P0DMS8 2/20 0.46
ADORA2A P29274 2/20 0.46
ADORA1 P30542 2/20 0.46
ADORA2B P29275 2/20 0.42
PI4KA P42356 1/20 0.42
PI4K2B Q8TCG2 1/20 0.42
PI4K2A Q9BTU6 1/20 0.42
PI4KB Q9UBF8 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
BRD4 O60885 1/20 0.39
XDH P47989 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5438910 0.83 NPC1 (0.52) MEN1KMT2AADORA3ADORA2AADORA1
SCHEMBL5429558 0.83 MEN1 (0.40) MEN1KMT2AADORA2BCA12CA1
SCHEMBL5428700 0.83 ADORA2A (0.45) MEN1KMT2AADORA3ADORA2AADORA1
SCHEMBL5438382 0.79 ALDH1A1 (0.39) MEN1KMT2AADORA3ADORA2AADORA1
SCHEMBL5769122 0.79 MEN1 (0.56) MEN1KMT2AADORA3ADORA2AADORA1
SCHEMBL23989088 0.76 DYRK1A (0.37) MEN1KMT2AADORA3ADORA2AADORA1
SCHEMBL5432006 0.76 POLB (0.39) KMT2ACA12CA1CA2CA9
SCHEMBL14441125 0.76 ALDH1A1 (0.45) ADORA3ADORA2AADORA1ADORA2BALDH1A1
SCHEMBL5768965 0.75 MEN1 (0.51) MEN1KMT2AADORA3ADORA2AADORA1
SCHEMBL4069308 0.74 ADORA3 (0.60) MEN1KMT2AADORA3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) BAYLISS TRACY 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) TRPV1, TRPV2, TRPV4 MEN1 4674/4885KMT2A 4422/4885ADORA3 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.